Quant grade B for BIIB, from a quantitative model before the open on Oct 30.
Quant grade · model v1 · before the open, Oct 30
B
Grade B
Band since
—
20 sessions
B
Model
v1
Price and quant grade
SABCD
Comparable companies
| Company | Grade |
|---|---|
| Alnylam Pharmaceuticals ALNY | S |
| Eli Lilly LLY | S |
| Gilead Sciences GILD | S |
| Incyte INCY | S |
| Amgen AMGN | A |
| Vertex Pharmaceuticals VRTX | A |
| Biogen BIIB | B |
| Regeneron REGN | B |
Recent sessions
| Date | Grade |
|---|---|
| Oct 30 | B |
Healthcare
S 13A 19B 21C 3D 3
- BIIB's grade
- B
- Graded in the sector
- 59
The model
- Version
- v1
- Graded
- each NYSE trading day, before the open
- This morning
- Oct 30, 2026
- Grades
- S (the best) to D (the worst)